You searched for "ears"

2208 results found

Unpacking the World Health Organization’s World Report on Hearing: what does it say?

The inaugural report on hearing from the World Health Organisation is a tool for advocacy, and for getting hearing loss on government agendas. Nguyen Ngoc Bao Tran was 11 months old when her hearing loss was diagnosed. Despite being informed...

Nottingham hearing experts launch CHEAR (COVID and hearing) study

Researchers based in Nottingham are launching an in-depth and ongoing study into the possible effects of COVID-19 on patients’ hearing, tinnitus and balance. The CHEAR (COVID and hearing, otherwise known as ‘Measuring Hearing, Tinnitus and Balance following COVID-19’) Study will...

Subtypes of vestibular migraine

The authors argue that the current Barany criteria (ICVD) for vestibular migraine (definite and probable – dVM and pVM) are too restrictive. For instance, whereas a category of chronic migraine with or without aura is recognised in ICHD-3, ‘chronic VM’...

Lost and sound: exploring hyperbaric oxygen therapy for refractory SSNHL

Can hyperbaric oxygen therapy (HBOT) offer a breakthrough for patients with refractory sudden sensorineural hearing loss (SSNHL)? SSNHL is defined as acute hearing loss of ≥30 decibels in three consecutive frequencies within three days. Typically, it’s treated with two weeks...

Lenire®, the tinnitus treatment device, now available in Norway

Neuromod Devices Ltd., has reached an agreement with HØR AS, Norway’s largest private provider of hearing and tinnitus care, to make its Lenire tinnitus treatment device available in Norway.

Neuromod publishes results of second large-scale clinical trial for tinnitus, shows greater improvement of symptoms

Neuromod Devices, the medical device company specialising in tinnitus, has published the results of its TENT-A2 (Treatment Evaluation of Neuromodulation for Tinnitus – Stage A2) clinical trial in the scientific journal, Nature – Scientific Reports in a paper titled ‘Different bimodal neuromodulation settings reduce tinnitus symptoms in a large randomized trial’.

'Deafmetals' on display at the V&A

Ground-breaking designs in hearing aids are on display as part of a new exhibition at the V&A Museum in London. Deafmetal®, founded by Finnish designer Jenni Ahtiainen, transforms hearing instruments into bold, beautiful jewellery – known as Deafmetals – helping wearers reclaim their identity.

Neuromod advances multiple regulatory approvals to expedite Lenire’s global availability

Neuromod, the medical technology company that created the Lenire® tinnitus treatment device, has announced approval to the Medical Device Single Audit Program (MDSAP) and EU Medical Device Regulation (MDR) certification. Neuromod’s MDSAP certification follows a comprehensive audit verifying compliance with...

Cambodian otology service – a fellowship with a difference

Cambodia is a country of 15 million people, still recovering from a chequered past. In the 1970s, under the Khmer Rouge, most of the medical profession, together with the rest of the educated population, was executed – the fortunate few...

Birmingham 2020 – think big, think BACO

When Richard Irving and Ann-Louise McDermott made their successful bid to host BACO 2020 in Birmingham, they knew it had far more going for it than the International Conference Centre! Lucy Dalton tells us a little more about the attractions...

From the editor JulyAugust 2022

Declan Costello, MA, MBBS, FRCS(ORL-HNS), Editor, ENT & Audiology News; Consultant Ear, Nose and Throat Surgeon, Wexham Park Hospital, Slough, Berkshire, UK. E: d.costello@nhs.net One of the joys of attending meetings and conferences is the chance to catch up with...

The 66th Hallpike Symposium - BAAP

The 66th Hallpike Symposium took place on the 15th November 2024. It was organised by Drs Carolyn Ainsworth and Rosa Crunkhorn, Audiovestibular Medicine (AVM) Consultants at Guy’s and St Thomas’ NHS Foundation Trust, London. The theme of the event was ‘Recognising systemic conditions associated with audiovestibular dysfunction for the practicing clinician’.